EGFR mutants found in tumor patients are not internalized or transported to the MVBs/lysosomes, resulting in enhanced and prolonged activation of EGFR and its downstream MAPK signaling that is essential for tumor cell proliferation and invasion (Huang et al., 2006; Goh et al., 2010). Here, EGFR is linked to neoplasm.